Yasuji Seyama

Tokyo Metropolitan Komagome Hospital

Papers

1

Total Citations

3

H-Index

1

About

Yasuji Seyama is a clinician-researcher whose work centers on the hepatobiliary complications of modern cancer therapies, with a particular focus on oxaliplatin-induced liver injury. His most cited study, published in 2023, documents a rare case of localized peliosis hepatis—a condition characterized by blood-filled cavities in the liver—that arose during adjuvant chemotherapy for colon cancer and was initially mistaken for a metastatic lesion. This contribution is critical for oncologists and radiologists, as it highlights a diagnostic pitfall that could lead to unnecessary surgical interventions. By detailing the imaging and histopathological features of this oxaliplatin-related toxicity, Seyama provides a valuable reference for distinguishing treatment-induced liver changes from true disease progression. Though his citation count is modest, the clinical significance of his work is substantial: it directly informs the safe management of colorectal cancer patients receiving platinum-based regimens. His research underscores the importance of recognizing chemotherapy-associated hepatic lesions, thereby preventing misdiagnosis and improving patient outcomes in oncology practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Tokyo Metropolitan Komagome Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago